Quality education, health services drive family size in India
17 OCT - Sanchita Sharma
Real progress happens in states with high literacy and when people regard fertility a conscious choice that they can control. Reliable methods of contraception must also be widely available.
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
17 OCT - Gouglas, et al.
The Coalition for Epidemic Preparedness Innovations was established in 2016, to develop vaccines that can contribute to preparedness for outbreaks of epidemic infectious diseases. Evidence on vaccine development costs for such diseases is scarce. Our goal was to estimate the minimum cost for achieving vaccine research and development preparedness targets in a portfolio of 11 epidemic infectious diseases, accounting for vaccine pipeline constraints and uncertainty in research and development preparedness outcomes.
Vietnam bolsters sci-tech ties in health care with foreign partners
17 OCT - The World Health Organisation (WHO) has announced that Vietnam has eliminated lymphatic filariasis as a public health problem.
The painful and profoundly disfiguring visible manifestations of the disease – lymphoedema, elephantiasis and scrotal swelling – occur later in life and can lead to permanent disability.
Podcast: Executive Director of The Global Fund Discusses Next Steps
17 OCT - In this episode of Take as Directed, we hear from Peter Sands, Executive Director of The Global Fund to Fight AIDS, Tuberculosis, and Malaria, about his reflections on his first 7 months in that post, takeaways from the UNGA high-level meeting on tuberculosis, as well as his expectations for the lead-up to the 2019 Global Fund replenishment conference, set to take place in France. He also discusses the importance of creative financing needed to achieve The Global Fund’s goal of investing resources to end the pandemics of HIV/AIDS, tuberculosis, and malaria.
Report highlights declining sales of vet antibiotics in Europe
16 OCT - A report yesterday from the European Medicines Agency (EMA) shows a significant drop in overall sales of veterinary antibiotics across Europe. "Reduction in sales is the result of combined efforts of the European Commission, EMA, EU Member States, veterinarians, farmers and other actors in the livestock sector," the agency said in a press release. Reducing the use of antibiotics in food-producing animals is a key pillar of the EU's One Health Action Plan against Antimicrobial Resistance (AMR), which aims to slow the emergence and spread of drug-resistant pathogens in humans, animals, and the environment.
South Korea declares end to MERS outbreak
16 OCT - South Korea on Tuesday officially declared an end to the country's first Middle East Respiratory Syndrome outbreak in three years, health authorities here said. The announcement made at midnight is in line with guidelines set by the World Health Organization that requires no new infections for a minimum of 28 days, which is twice the length of the virus' incubation period.
The biggest pandemic risk? Viral misinformation
16 OCT - Heidi J. Larson
I predict that the next major outbreak — whether of a highly fatal strain of influenza or something else — will not be due to a lack of preventive technologies. Instead, emotional contagion, digitally enabled, could erode trust in vaccines so much as to render them moot. The deluge of conflicting information, misinformation and manipulated information on social media should be recognized as a global public-health threat.
At WHO regional meeting, an urge for better health systems
15 OCT - The annual regional meeting of the World Health Organization’s Western Pacific office concluded Friday, with a new regional director, several new regional frameworks and actions plans, and a reminder that amid recent health successes, the region still has much to do to improve health systems and eliminate deadly diseases.
WHO: Southern Hemisphere flu activity tapering off in most locations
15 OCT via CIDRAP - Southern Hemisphere flu activity continues to taper off, except for Southern Africa, where high levels of flu from both influenza B lineages are reported, the World Health Organization (WHO) said in its latest global flu update. As the region nears the end of its typical flu season, flu activity seems to have peaked in Australia and New Zealand without levels passing seasonal thresholds during the entire season.
Patent filings for AMR point-of-care tests are declining, with funds lacking
15 OCT - Patent filings for point-of-care (POC) diagnostic tests for antimicrobial resistance have been slowly declining since reaching their peak in 2014, according to a study commissioned by the Longitude Prize, a UK program launched in 2014 to spur the development of such tests. The 14-page study was conducted by two intellectual property firms and released on Oct 14 at the World Health Summit in Berlin.
Among other findings, the United States dominated the filings for patents for new tests, with 60%, followed by the United Kingdom with 8%. Japan, Australia, India, and South Africa all saw upward trends. Innovations for POC tests are led by private companies, accounting for 60% in the United States and Europe, and academic institutions were responsible for 32%.